Skip to main content

ENGLISH · EVIDENCE OVERVIEW

Sildenafil
evidence profile

Phosphodiesterase type 5 (PDE5) inhibitor. This is a concise English overview, not a full translation. Read the evidence boundaries and original sources below; the detailed study and risk discussion remains available in Thai.

What do Class, Grade and Risk mean?

Sildenafil: conceptual scientific illustration for Sexual Medicine Pharmacology
VISUAL GUIDE · Sildenafil

Sexual Medicine Pharmacology

Category-level conceptual illustration, not a map of this molecule's receptor targets. It is not a treatment outcome and does not establish efficacy or safety.

QUICK ANSWER · AEO / GEO

A PDE5 inhibitor with separate approved products for erectile dysfunction and pulmonary arterial hypertension; molecule identity does not make brands, formulations or indications interchangeable.

01

ENTITY FACTS

What should readers identify first?

MOLECULESildenafil
PHARMACOLOGYPhosphodiesterase type 5 (PDE5) inhibitor
PRIMECORE CLASSA
EVIDENCE GRADEA
RESEARCH TOPICSexual Medicine Pharmacology
LAST REVIEWED2026-08-29

What remains unknown?

English translation is not yet verified for 3 excerpt(s). This is a language gap, not an absence of risks or uncertainty.

Read original excerpts (Thai / mixed language)
  • Viagra ไม่ใช่ชื่อแทน sildenafil ทุกผลิตภัณฑ์
  • หลักฐาน ED ไม่ใช้ยืนยันประโยชน์ PAH ของสูตรอื่นโดยอัตโนมัติ
  • ไม่ใช่ยากระตุ้นความต้องการทางเพศและไม่ป้องกันโรคติดต่อทางเพศสัมพันธ์

What limits these conclusions?

Insufficient data in the current dataset

This overview does not replace the detailed adverse-event and product-specific risk discussion in the complete Thai profile or the original sources.

02

EVIDENCE BOUNDARY

What this overview does not establish

  • An evidence grade does not rank this molecule against another treatment.
  • A molecule name does not establish the identity, purity or regulatory status of a product.
  • Animal, cell or biomarker findings do not automatically establish human clinical benefit.
  • Approval in one country or indication does not transfer globally.

Where can I check the evidence?

Original sources from the same evidence record used by Compare. Read each source's population, methods, limitations and date; a citation is not product endorsement.

  1. Thai FDA — Viagra product record
  2. DailyMed — sildenafil ED label
  3. U.S. FDA — Revatio prescribing information
  4. EAU — Management of erectile dysfunction
03

FAQ · ANSWER ENGINE

Frequently asked questions

What is Sildenafil?

Sildenafil is described pharmacologically as Phosphodiesterase type 5 (PDE5) inhibitor. A PDE5 inhibitor with separate approved products for erectile dysfunction and pulmonary arterial hypertension; molecule identity does not make brands, formulations or indications interchangeable.

Does Sildenafil have strong evidence?

PrimeCoreBio records Evidence Grade A. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.

Is Sildenafil approved everywhere?

No global conclusion should be inferred. PrimeCore Class A must be read with the exact product, country and indication on the source-rich profile.

Medical Disclaimer

Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.

Contact PrimeCoreBio

Choose a contact channel

General information only · No sales or medical advice